Evidence map›Paper›PMID 38555298›Full record

ArticleNature communications2024

A conserved NR5A1-responsive enhancer regulates SRY in testis-determination.

Denis Houzelstein, Caroline Eozenou, Carlos F Lagos, Maëva Elzaiat, Joelle Bignon-Topalovic, Inma Gonzalez, Vincent Laville, Laurène Schlick, Somboon Wankanit, Prochi Madon and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Molecular Diagnosis of 46,XY Disorders of Sex Development: An Efficient Initial Molecular Analysis Using a Custom-Designed Targeted Gene Panel in a Single-Center Study.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2026
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 6 countries.

Denis HouzelsteinInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France. denis.houzelstein@cnrs.fr.ORCID http://orcid.org/0000-0002-8536-9039
Caroline EozenouInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.ORCID http://orcid.org/0000-0001-6968-0110
Carlos F LagosChemical Biology & Drug Discovery Lab, Escuela de Química y Farmacia, Facultad de Medicina y Ciencia, Universidad San Sebastián, Campus Los Leones, Lota 2465 Providencia, 7510157, Santiago, Chile.ORCID http://orcid.org/0000-0002-5432-9747
Maëva ElzaiatInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.ORCID http://orcid.org/0000-0002-0499-1724
Joelle Bignon-TopalovicInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.
Inma GonzalezCentre National de la Recherche Scientifique, CNRS, UMR 3738, Paris, France.ORCID http://orcid.org/0000-0003-2523-499X
Vincent LavilleCentre National de la Recherche Scientifique, CNRS, UMR 3738, Paris, France.ORCID http://orcid.org/0000-0003-4946-698X
Laurène SchlickInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.
Somboon WankanitInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.
Prochi MadonDepartment of Assisted Reproduction and Genetics, Jaslok Hospital and Research Centre, Mumbai, India.ORCID http://orcid.org/0000-0002-7394-6345
Jyotsna KirtaneDepartment of Pediatric Surgery, Jaslok Hospital and Research Centre, Mumbai, India.
Arundhati AthalyeDepartment of Assisted Reproduction and Genetics, Jaslok Hospital and Research Centre, Mumbai, India.ORCID http://orcid.org/0000-0002-0480-6226
Federica BuonocoreGenetics and Genomic Medicine Research & Teaching Department, UCL GOS Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-8274-7241
Stéphanie BigouICV-iPS core facility, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0002-6328-0703
Gerard S ConwayInstitute for Women's Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0002-3346-5029
Delphine BohlICV-iPS core facility, Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.ORCID http://orcid.org/0000-0001-8262-5642
John C AchermannGenetics and Genomic Medicine Research & Teaching Department, UCL GOS Institute of Child Health, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-8787-6272
Anu BashambooInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France.
Ken McElreaveyInstitut Pasteur, Université Paris Cité, Human Developmental Genetics Unit, F-75015, Paris, France. kenneth.mcelreavey@pasteur.fr.ORCID http://orcid.org/0000-0001-6582-1801
Centre National de la Recherche Scientifique · FRJaslok Hospital · INUniversity College London · GBLondon Women's Clinic · GBSan Sebastián University · CL

Funding

Wellcome Trust
6 · The paper itself

Abstract

The Y-linked SRY gene initiates mammalian testis-determination. However, how the expression of SRY is regulated remains elusive. Here, we demonstrate that a conserved steroidogenic factor-1 (SF-1)/NR5A1 binding enhancer is required for appropriate SRY expression to initiate testis-determination in humans. Comparative sequence analysis of SRY 5' regions in mammals identified an evolutionary conserved SF-1/NR5A1-binding motif within a 250 bp region of open chromatin located 5 kilobases upstream of the SRY transcription start site. Genomic analysis of 46,XY individuals with disrupted testis-determination, including a large multigenerational family, identified unique single-base substitutions of highly conserved residues within the SF-1/NR5A1-binding element. In silico modelling and in vitro assays demonstrate the enhancer properties of the NR5A1 motif. Deletion of this hemizygous element by genome-editing, in a novel in vitro cellular model recapitulating human Sertoli cell formation, resulted in a significant reduction in expression of SRY. Therefore, human NR5A1 acts as a regulatory switch between testis and ovary development by upregulating SRY expression, a role that may predate the eutherian radiation. We show that disruption of an enhancer can phenocopy variants in the coding regions of SRY that cause human testis dysgenesis. Since disease causing variants in enhancers are currently rare, the regulation of gene expression in testis-determination offers a paradigm to define enhancer activity in a key developmental process.

Indexed as

Gonadal DysgenesisTestisAnimalsCell LineFemaleHigh-Temperature Requirement A Serine Peptidase 2HumansMaleMammalsRegulatory Sequences, Nucleic AcidSertoli CellsSex-Determining Region Y ProteinSteroidogenic Factor 1High-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanNR5A1 protein, humanSex-Determining Region Y ProteinSRY protein, humanSteroidogenic Factor 1

Identifiers

PMID38555298
PMCPMC10981742
OpenAlexW4393350148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.